vatalanib has been researched along with tg101209 in 1 studies
| Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) | Studies (tg101209) | Trials (tg101209) | Recent Studies (post-2010) (tg101209) |
|---|---|---|---|---|---|
| 276 | 42 | 98 | 36 | 0 | 31 |
| Protein | Taxonomy | vatalanib (IC50) | tg101209 (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase JAK2 | Homo sapiens (human) | 0.006 | |
| Bromodomain-containing protein 4 | Homo sapiens (human) | 0.13 | |
| Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | 3.5 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.025 | |
| Bromodomain testis-specific protein | Homo sapiens (human) | 0.23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB | 1 |
1 other study(ies) available for vatalanib and tg101209
| Article | Year |
|---|---|
Navigating the kinome.
Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology | 2011 |